Establishment of Asia-Pacific Network for Enterovirus Surveillance

Chiu, Mu-Lin and Luo, Shu Ting and Chen, Ya-Yen and Chung, Wan Yu and Duong, Veasna and Dussart, Philippe and Chan, Yoke-Fun and Perera, David and Ooi, Mong How and Thao, Nguyen Thi Thanh and Truong, Huu Khanh and Lee, Min-Shi (2019) Establishment of Asia-Pacific Network for Enterovirus Surveillance. Vaccine. pp. 1-9. ISSN 0264-410X

PDF Chiu, Mu-Lin.pdf Download (1MB)

Abstract

Enteroviruses (EV), the major pathogens of hand, foot, and mouth disease (HFMD) and herpangina, affect millions of children each year. Most human enteroviruses cause self-limited infections except polioviruses, enterovirus A71 (EV-A71), enterovirus D68 (EV-D68), and several echoviruses (Echo) and coxsackieviruses (CV). Especially, EV-A71 has repeatedly caused large-scale outbreaks in the Asia-Pacific region since 1997. Some Asian countries have experienced cyclical outbreaks of severe EV-A71 infections and initiated development of EV-A71 vaccines. Five EV-A71 vaccine candidates have been clinically evaluated and three of them were approved for marketing in China. However, none of the China-approved products seek marketing approval in other countries. This situation supports a role for collaboration among Asian countries to facilitate clinical trials and licensure of EV-A71 vaccines. Additionally, enterovirus D68 outbreaks have been reported in the US and Taiwan currently and caused severe complications and deaths. Hence, an Asia-Pacific Network for Enterovirus Surveillance (APNES) has been established to estimate disease burden, understand virus evolution, and facilitate vaccine development through harmonizing laboratory diagnosis and data collection. Founded in 2017, the APNES is comprised of internationally recognized experts in the field of enterovirus in Asian countries working to raise awareness of this potentially fatal and debilitating disease. This article demonstrated the summaries of the first expert meeting, 2017 International Workshop on Enterovirus Surveillance and Vaccine Development, held by APNES in Taipei, Taiwan, March 2017.

Actions (For repository members only: login required)

View Item